Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Dec 14, 2021 7:38pm
90 Views
Post# 34231027

RE:RE:What is (or may be) changing over the next 2 -3 weeks ?

RE:RE:What is (or may be) changing over the next 2 -3 weeks ?

other little things here and there.

if they found a major to partner with for DIMI. Start of that trial etc. 


but none of that is game changing. Neither is end of tax loss. Anyways I don't see it taking the stock back to above 50 cents. Especially with investor confidence being crushed with that last financing. Many like myself will be rightfully gunshy of being blidnsided with something similar. 


Domino55 wrote: MM: I know that tax loss selling is an annual and unique
holiday ritual with Spectral, but not all late stage  P3 companies dress themselves up as failures. This years extra special feature is we hit tax loss time at all time lows and now 2% of NPV after losing 65% of market cap over a special 6 month period of devaluation. All this while the company celebrates(quietly) a trial surpassing expectations.

if you had to pick a quarter for them to start trying to fairly value our company what would you chose? Would it be next year?

 

<< Previous
Bullboard Posts
Next >>